Last week on the show we started our conversation on search in life sciences, particularly the challenges faced by pharmaceutical organizations as they adapt to regulation through mergers and acquisitions, heavy research and development, clinical trials, sales and marketing, and the force that is put on data requirements in these organizations as a result.

This week, BA Insight's Jeff Fried continues the story of search in life sciences with two cases that showcase the power of data to combat the risks of ballooning research costs, soften the cultural rifts that come from access to information, and improving efficiency by de-duplicating efforts to stunning results. 

Links & Notes